NCT05431530Recruiting
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
Assessment of Quality of Life After Low Anterior Resection or Visceral Peritoneal Stripping During cytOreDuctive surgerY for Advanced Ovarian Cancer Requiring Tumor Resection on the Rectosigmoid Colon: a Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 27 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 108 (estimated)
- First submitted
- 19 Jun 2022
- Start date
- 22 Jun 2022
- Primary completion date
- 31 May 2027
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Ovarian cancer
- NCT number
- NCT05431530
What you commit to
- Study type: Observational
- Planned participants: 108
- From 22 Jun 2022 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient who underwent low anterior resection in the past
- Patient who underwent radiation therapy to abdominal or pelvic cavity
Other illness
- Past history of gastrointestinal malignant tumor except to ovarian cancer
- Patient who have intellectual disability or dementia
Other
- Patient who have colostomy
- ECOG performance status over 3
- Patient taking opioid analgesics
Who the study is looking for
- Those with newly diagnosed ovarian cancer, fallopian tube cancer and primary peritoneal carcinomatosis who plan to undergo cytoreductive surgery and secondary cytoreductive surgery after neoadjuvant chemotherapy.
- Patients with PCDS or rectal and sigmoid coloni tumor invasion suspected on the preoperative image and need resection of the tumor and clinical FIGO stage IIIB or higher
- ECOG performance status : 0-2
- Age over 18
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.